Taurosteine
- Level
- Commodity
- Parent
- 51162700
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51162741This classification denotes a mucolytic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 43A07PH183. European Medicines Agency schedules Taurosteine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10840MIG. Taurosteine generally arises in the molecular formula C7H9NO4S2. The term TAUROSTEINE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 5, no. 3 1991, list 31.) TAUROSTEINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule taurosteine under HS 29349990 and SITC 51579. As of Q4 2014, TAUROSTEINE remains US FDA's Preferred Term for this commodity. Taurosteine bears US NLM identifiers UMLS ID C2699896 and NCI Concept Code C74549. SMILES: S(=O)(=O)(O)CCNC(=O)C1SCCC1.
Same parent
Under 51162700 · 48Activities that produce or sell this
KBLI · 9Inherited from family 51160000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.